To study the clinical efficacy of Shendan infusion in treating fetal growth restriction(FGR). Methods: A total of 80 pregnant women who were diagnosed of FGR in our hospital were divided into treatment group and control group, with 40 cases in each group. Also, there were 40 cases of normal pregnant women composed of normal group. To observe the uterine height, abdominal circumference, fetal biparietal diameter, femur length and umbilical blood flow indicators (S/D、PI、RI) of the control group and treatment group weekly before and after the treatment and to compare the weight and Apgar score at birth. Results: 1)The increase of the uterine height, abdominal circumference, biparietal diameter, femur length in the treatment group are higher than those of the control group(P<0.05). 2) After treatment, S/D、PI、RI of the treatment group are lower than that of the control group(P<0.05). 3) The birth weight of the treatment group is higher than that of the control group but lower than normal group(P<0.05). Conclusion: Danshen infusion is effective on the treatment of FGR.